Navigation Links
Lung Cancer May Be Deadlier for Men
Date:11/13/2008

Gender is the major socioeconomic factor influencing outcomes, study finds

THURSDAY, Nov. 13 (HealthDay News) -- Men are more likely to die from inoperable non-small cell lung cancer than women, U.S. researchers report.

In fact, gender is the most important factor influencing overall survival of patients with this disease, the new study found.

A team of researchers in six U.S. cities studied 1,365 patients enrolled in national group trials to determine the effect of such sociodemographic factors as gender, race and marital status on lung cancer outcomes.

They found that men had a 1.23 times higher death rate than women, while race and marital status didn't significantly affect outcomes.

"Our study corroborates the fact that gender plays an important role as a prognostic factor in people diagnosed with lung cancer," the lead author, Dr. Benjamin Movsas, chair of the radiation oncology department at Henry Ford Hospital in Detroit, said in a news release. "This underscores the importance of studying this disease entity in light of the fact that women diagnosed with lung cancer tend to have a better outcome in terms of survival."

The study was to be presented Thursday at the Chicago Multidisciplinary Symposium in Thoracic Oncology.

At the same meeting, another group of U.S. researchers, from the South West Oncology Group, reported that a combination of traditional chemotherapy with targeted therapies called monoclonal antibodies was safe and improved survival of patients with advanced non-small cell lung cancer.

The study found that the use of two targeted therapies (bevacizumab and cetuximab) with chemotherapy (carboplatin and paclitaxel) as first-line treatment improved the survival of 104 patients who were evaluated between August 2006 and September 2007. There were no safety concerns.

"The combination of multiple targeted therapies in addition to chemotherapy may be the future of treatment in lung cancer," lead author Dr. Edward Kim, an assistant professor in the department of thoracic/head and neck medical oncology at M.D. Anderson Cancer Center in Houston, said in a news release. "Blocking more key cancer pathways such as the epidermal growth factor receptor and vascular endothelial growth factor may lead to improved cancer control."

In 2008, about 215,000 new cases of lung cancer will be diagnosed in the United States and 161,840 people will die from the disease, according to the U.S. National Cancer Institute.

More information

The American Cancer Society has more about non-small cell lung cancer.



-- Robert Preidt



SOURCE: American Society for Therapeutic Radiology and Oncology, news releases, Nov. 13, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Cancer treatment may result in bone loss
2. American Academy of Dermatology: Stop Skin Cancer On The Spot
3. Gender is key factor in determining overall survival of lung cancer patients
4. Proton therapy may reduce serious side effect of lung cancer treatment
5. Tissue analyses indicate survival benefits for some lung cancer patients
6. Advanced lung cancer patients see improved, progression-free survival
7. Chemotherapy plus targeted therapies shows improved survival in advance-stage lung cancer patients
8. Research demonstrates differing genetic makeup of lung cancer in African-American patients
9. Novel 4-drug combination proves safe for lung cancer treatment
10. US Oncology Applauds Senator Baucuss Healthcare Reform Call to Action for 2009, Supports Collaborative Measures to Enhance Cancer Patients Access to Care While Improving Quality and Access
11. AACR to host 7th Annual International Conference on Frontiers in Cancer Prevention Research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lung Cancer May Be Deadlier for Men
(Date:10/13/2017)... ... October 13, 2017 , ... ... Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate ... primary prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the Mission ... lost souls in the Philippines. “The Journey: From the Mountains to the Mission Field” ... the Bible. She has taught all ages and currently teaches a class of ladies ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa ... contributed a medical article to the newly revamped Cosmetic Town journal ... the hair transplant procedure known as Follicular Unit Extraction (FUE). , ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... --  Divoti USA will engrave and process all ... the latest FDA requirements, which stipulates new criteria regarding medical device ... of Medical ID jewelry such as Medical ID Bracelets, can rest ... terms of the new FDA requirements . ... Divoti offers this dark mark fiber laser engraving ...
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: ... that developed an innovative way to use nonlinear optical ... delivery of new drugs. ... Dermatology Conference will show how researchers from BioPharmX and ... Medical School used a suite of imaging techniques in ...
(Date:10/11/2017)... , Oct. 11, 2017  True Health, ... has amplified its effort during National Breast Cancer ... hereditary cancer risks. ... Clinical Oncology calculated that more than 10 million ... inherited mutations in BRCA1 or BRCA2 and have not ...
Breaking Medicine Technology: